- Open
- 0.60
- High
- 0.65
- Low
- 0.59
- Close
- 0.65
- Change
- -0.05 (-8.33%)
- Volume
- 2,596,234
⌘K
| 13 Apr 2026 | 13:08:42 | Result of General Meeting |
| 31 Mar 2026 | 07:00:06 | Result of Retail Offer and Posting of Notice of GM |
| 26 Mar 2026 | 07:05:01 | Retail Offer to raise up to £0.5 million |
| 26 Mar 2026 | 07:00:06 | Results of Placing |
| 25 Mar 2026 | 07:10:02 | Interim Results and Notice of Investor Webinar |
| 16 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 19 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 12 Jan 2024 | Annual Report and Accounts (to 2023-06-30) |
A leading provider of custom Optimer® selection and development services, Aptamer Group utilises cutting-edge, high-throughput automated technologies to deliver aptamer-based solutions globally. With a focus on innovation in life sciences, the company offers high affinity, high specificity, high stability, and cost-effective production across various therapeutic, diagnostic, and target-binding applications.
| 13 Apr 2026 | 13:08:42 | Result of General Meeting |
| 31 Mar 2026 | 07:00:06 | Result of Retail Offer and Posting of Notice of GM |
| 26 Mar 2026 | 07:05:01 | Retail Offer to raise up to £0.5 million |
| 26 Mar 2026 | 07:00:06 | Results of Placing |
| 25 Mar 2026 | 07:10:02 | Interim Results and Notice of Investor Webinar |
| 16 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 19 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 12 Jan 2024 | Annual Report and Accounts (to 2023-06-30) |
A leading provider of custom Optimer® selection and development services, Aptamer Group utilises cutting-edge, high-throughput automated technologies to deliver aptamer-based solutions globally. With a focus on innovation in life sciences, the company offers high affinity, high specificity, high stability, and cost-effective production across various therapeutic, diagnostic, and target-binding applications.